glp-1 receptor agonist common side effects and How to Manage Them PDF) Exploring the Side Effects

Our medical team will carefully evaluate your health and determine if tirzepatide is an appropriate option for you

Compounded GLP-1 products are not FDA-approved finished drug products, have not been individually evaluated by the FDA for safety or effectiveness, and have not been evaluated for bioequivalence to brand-name semaglutide or tirzepatide

Many studies have proved that gastric emptying rates consistently show inter-individual variation in the general population [18]

According to the USPSTF, the evidence supports referring all adults with obesity to intensive, multicomponent behavioral interventions for both weight reduction and weight maintenance

Also, it has not yet been studied in patients with history of pancreatitis, an issue with other GLP-1 agonists